ArticleBMC public health2025
Prevalence and predictors of anxiety and depression among breast cancer patients in low-and middle-income countries: a cross-sectional study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Influencing Factors of Anxiety and Depression in Patients With Breast Cancer: A Meta-Analysis.Actas espanolas de psiquiatria · 2026Pooled it
- Prevalence and Determinants of Depression, Anxiety, and Quality of Life in Patients With Breast Cancer in Saudi Arabia: A Focus on Adjuvant Pharmacotherapy.Cancer medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBreast cancer diagnosis and treatment can be profoundly traumatic for women, often affecting psychological well-being, with many experiencing anxiety and depression especially in resource limited settings. This study examines the prevalence and predictors of anxiety and depression in breast cancer patients in Abbottabad, Pakistan. METHODOLOGY: A cross-sectional study was conducted on 96 female breast cancer survivors receiving treatment (October 2023 to May 2024) at the Islamabad Diagnostic Center Breast Cancer Clinic and Ayub Teaching Hospital MTI. Anxiety and depression were assessed using the Generalized Anxiety Disorder-7 Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9).
resultsThe study population was characterized by a high proportion of patients with no formal education (52.1%) and unemployment (91.7%). The prevalence of anxiety and depression was substantially high at 41.7% and 79.2%, respectively. Regression analysis identified age and stage of cancer as significant predictors of anxiety and depression. Multivariate logistic regression identified younger age (20-40 years) and Stage 2 Cancer (compared to Stage 4) as significant predictors of anxiety, while age (41-60 years) was the main significant predictor of depression.
conclusionThe high burden of depression (79.2%) and anxiety (41.7%) among breast cancer patients in this low-income setting is alarming. Age and cancer stage are critical predictive factors, underscoring the need for targeted mental health interventions and support strategies for younger patients and those in earlier stages of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.